UT Southwestern faculty have discovered what appears to be an Achilles’ heel in ovarian cancers, as well as new biomarkers that could point to which patients are the best candidates for possible new treatments.
Curadev Pharma, India and UT Southwestern Medical Center in Dallas, USA have announced a translational research partnership to identify small molecule drugs for the treatment of specific cancers.